La transmisión VIH de varón a mujer es más efectiva que de mujer a varón
La probabilidad de transmisión de VIH de mujer a varón es más baja que la de varón a mujer, a no ser que haya alta carga viral y ulceración genital. Esto es incompatible con la idea de que en Argentina hay tantas mujeres infectadas por varones como varones infectados por mujeres. Dejamos en inglés las partes más técnicas del artículo.
THE LANCET, Volume 357: Pages 1149-1153, 14 April 2001.
Probabilidad de transmisión HIV-1 por acto coital en parejas discordantes al HIV-1 de Rakai, Uganda
Ronald H Gray, Maria J Wawer, Ron Brookmeyer, Nelson K Sewankambo, David Serwadda, Fred Wabwire-Mangen, Tom Lutalo, Xianbin Li, Thomas vanCott, Thomas C Quinn, and the Rakai Project Team*
*Members listed at end of paper
Trasfondo La probabilidad de transmisión HIV-1 por acto coital en poblaciones africanas representatives as desconocida. Apuntamos a calcular esta probabilidad en conjunto, y a estimar cómo es afectada por factores diversos de los que se piensa que influyen en la infecciosidad.
Methods 174 monogamous couples, in which one partner was HIV-1 positive, were retrospectively identified from a population cohort in Rakai, Uganda. Frequency of intercourse and reliability of reporting within couples was assessed prospectively. HIV-1 seroconversion was determined in the uninfected partners, and HIV-1 viral load was measured in the infected partners. Adjusted rate ratios of transmission per coital act were estimated by Poisson regression. Probabilities of transmission per act were estimated by log-log binomial regression for quartiles of age and HIV-1 viral load, and for symptoms or diagnoses of sexually transmitted diseases (STDs) in the HIV-1-infected partners.
Resultados La frecuencia mediana de relación sexual penetrative fue 8·9 per mes, lo que declinaba con la edad y la carga viral HIV-1. Los miembros de las parejas informaron frecuencias de relación sexual penetrativa similares. La probabilidad no ajustada en general de transmisión de HIV-1 por acto coital fue 0·0011 (95% CI 0·0008-0·0015). Las probabilidades de transmisión aumentaban de 0·0001 por acto en cargas virales de menos de 1700 copias/mL a 0·0023 por act hasta 38 500 copias/mL o más (p=0·002), y eran 0·0041 con ulceración genital, versus 0·0011 sin ella (p=0·02). Las probabilidades de transmisión por acto no difirieron significativamente por subtipos de VIH-1 A y D, sexo, ETS, o síntomas de descarga o disuria en el miembro HIV positivo de la pareja.
Interpretación La carga viral más alta y la ulceración genital son los determinantes principales de la transmisión de HIV-1 por acto coital en esta población ugandesa.
Lancet 2001; 357: 1149-53
La probabilidad de transmisión de VIH por acto sexual de relación sexual penetrative vaginal, o infectividad (γ), ha sido estimada a partir de estudios prospectivos de miembros de parejas HIV-discordantes o por contactos de varones con prostitutas.1 Las estimaciones de probabilidades de transmisión por acto varían de γ=0·0001 to 0·0014 en estudios europeos y norteamericanos de parejas discordantes,2-6 y de γ=0·002 en parejas tailandesas.7 Sin embargo, probabilidades de transmisión superiors (γ=0·056-0·100 per act) han sido informadas entre hombres que tuvieron contacto con prostitutes en Tailandia y Kenia8 and Kenya.9 Las probabilidades de transmisión más altas asociadas con el sexo commercial pueden ser atribuibles a la presencia de otras enfermedades de transmisión sexual (ETS), de las que se piensa que aumentan la infectividad de o la susceptibilidad al HIV,2,8,9 o a posibles errores en la frecuencia de contacto notificada. Otros facgtores que aumentan la transmisión incluyen lios conteos de CD4 más bajos o SIDA en el miembro índice HIV positivo de la pareja, y la relación sexual penetrativa anal.2,5,8,9 La transmisión de varón a mujer as generalmente más eficiente que la transmisión de mujer a varón en poblaciones estadounidenses y europeas, pero la pequeña cantidad de miembros índice mujeres HIV positivas en las parejas ponen límite a las estimaciones concluyentes de probabilidades de tranbsmisión por acto sexual.2-5,10,11
There are no data on per-contact probability of transmission from representative heterosexual couples in sub-Saharan Africa, and there is little information on the efficiency of transmission associated with HIV-1 viral subtypes.2 The eastern and southern African HIV epidemic is predominantly caused by HIV-1 subtypes A, C, and D, and the rapid progression of the epidemic in these parts of Africa might, in part, be associated with greater infectivity of these HIV-1 subtypes.12 We assessed this possibility by examining transmission probabilities for subtypes A and D in Uganda. Conversely, some have postulated that the slower evolution of the HIV epidemic in western Africa might be due to the higher proportion of less transmissable recombinant HIV-1 subtypes in that region.13 To address these issues, we estimated the per-contact probability of HIV-1 transmission among monogamous, heterosexual HIV-1-discordant couples in rural Rakai District, Uganda, in which the HIV-1 epidemic is due to viral subtypes A and D. Estimates of HIV transmission probabilities rely on the accuracy of reports of the frequency of sexual intercourse,1 and previous studies have not assessed the reliability of such data. Therefore, we also assessed the intracouple reliability of reports of sexual frequency and examined factors such as age, sex, and viral load, which might be associated with frequency of intercourse.
Participants and methods
Data were collected between November, 1994, and October, 1998, in a community-randomised trial of STD control for AIDS prevention in the rural district of Rakai.14 The original trial enrolled 15127 individuals aged 15-59 years, who were followed up in their homes every 10 months.
Among the 15127 participants, 8898 were married or in a consensual union, and information was requested on the identity of their partners. However, to maintain confidentiality, linkage of members of couples was not done during the course of the study. After completion of the trial in 1998, we linked members of couples and identified 415 couples who, at enrolment, were HIV-1-discordant (ie, one member of the couple was HIV-1-positive whereas the other was HIV-1-negative).15 Both members of 174 such couples reported that they were monogamous and that the HIV-1-negative partner reported no extramarital partners during the period of observation. Data from these 174 monogamous couples were used to estimate the probabilities of HIV-1 transmission per coital act, since it was assumed that the only source of infection in the HIV-1-negative partner would be the linked HIV-1-positive partner. The information on usual frequency of intercourse had been collected from both members of the couples, but for these analyses we used the sexual frequency information reported by the HIV-1-positive partner.
Participants were enrolled as individuals, gave written informed consent at the time of enrolment, and were asked to give consent again at each follow-up visit. The consent form guaranteed complete confidentiality of the information provided. Voluntary HIV counselling and testing was offered, and condoms were promoted and provided free of charge by the project. In keeping with Ugandan governmental policy,16 receipt of HIV results was encouraged but not mandatory. Individual HIV results were kept strictly confidential, but recipients were encouraged to share their results with their sexual partners. Involuntary disclosure of results is not permitted under Ugandan governmental policy. The trial was reviewed and approved by institutional review boards at the Uganda Virus Research Institute, the AIDS Research Subcommittee of the Uganda National Council for Science and Technology, Columbia and Johns Hopkins University human subjects review boards, and the National Institutes of Health Office for Protection from Research Risk. Safety during the trial was assessed by an independent data safety and monitoring board.
At each 10-month contact, biological samples were collected, and interview information obtained on sociodemographic characteristics and sexual behaviours, including the number of partners and use of condoms. Additionally, participants were asked about the usual frequency of intercourse with each partner. The specific question was: "When you have/had relationships with this partner, how frequently did you usually have intercourse, per day, per week and per month?". This information was used to estimate the number of coital acts per follow-up period. Information was also obtained on symptoms suggestive of STDs such as genital ulcers, discharge, or dysuria during the preceding period of risk.
During the trial, participants were asked to provide a blood sample which was tested for HIV-1 by two different ELISAs (Vironostika HIV-1, Organon Teknika, Charlotte, NC, USA; and Cambridge Biotech, Worcester, MA, USA) with confirmation of discordant ELISAs by western blotting (HIV-1 Western Blot, Bio-Merieux-Vitek, St Louis, MO, USA). Serology was done for syphilis (Toluidine Red Unheated Serum Test [TRUST], New Horizons, Columbia, MD, USA), and TRUST-positive samples were confirmed by treponemal-specific tests (Treponema pallidum haemagglutination assay [Sera-Tek, Rujibero, Tokyo, Japan], or fluorescent treponemal antibody absorption test [IFA Test System, Zeus Scientific, Raritan, NJ, USA]). Herpes simplex virus type 2 (HSV-2) infection was detected by an enzyme-linked immunodot assay.17 Neisseria gonorrhoeae and Chlamydia trachomatis were detected by ligase chain reaction on urine samples (LCx Probe System, Abbott Laboratories, Abbott Park, IL, USA). In women, self-collected vaginal swabs were used for culture of Trichomonas vaginalis (InPouch TV culture, BioMed Diagnostics, San Jose, CA, USA), and bacterial vaginosis was detected by quantitative morphology of gram-stained slides.
The HIV-1 viral load for HIV-1-positive partners in discordant relationships was quantified by reverse-transcriptase PCR by use of an Amplicor HIV-1 Monitor 1.5 Assay (Roche Molecular Systems, Branchburg, NJ, USA), which reliably quantifies the predominant Ugandan HIV-1 subtypes A and D. HIV-1 subtypes were determined by peptide competition serotyping assay for V3-loop peptides of HIV-1 subtypes A-F and O.18 The sample for the viral load assay was the one taken from the index HIV-1-positive individual at the 10-month visit before detection of the seroconversion in the partner.15 This sample approximates to the HIV-1 viral load about 5 months before infection of the HIV-1-negative partner, assuming infection occurred uniformly throughout the interval of risk. Couples in whom no seroconversion occurred were matched to the seroconverting couples by age (to within 5 years), and sex of the HIV-1-positive and HIV-1-negative partners. The viral load assay in the HIV-1-positive partners of persistent discordant couples was determined for the sample obtained closest in time to that of the matched seroconverting partners. Thus, the viral loads of the HIV-1-positive transmitting partners were matched for age, sex, and time to the viral loads of the HIV-1-positive non-transmitting index partners. Repeat measurements of viral load were available for 43 non-transmitting, HIV-1-positive partners, so we used the mean of two or more viral loads to obtain a better measure of the mean exposure of the uninfected partner during the period of risk.
Antiretroviral drugs were not available in Uganda at the time of the study. The efficacy of trimethoprim-sulphamethoxazole prophylaxis for symptom-free HIV-1-infected individuals was not yet established, and because of concerns about resistance, the Ugandan Ministry of Health did not approve routine prophylaxis. Isoniazid prophylaxis for tuberculosis could not be provided because we were unable to exclude patients with active tuberculosis in this rural setting, and use of isoniazid in cases of active disease would rapidly select for resistant mycobacteria. The study provided STD treatment and general health care.
The statistical analysis first examined the reliability of the sexual frequency information reported by each member of a couple. We determined the within-couple differences in reported frequency of intercourse, and mean differences were assessed by paired t tests. We also estimated mean frequency of intercourse by sex, age, and viral load of the HIV-1-positive partner. The number of sex acts over the follow-up period was estimated from the intercourse frequency per month reported by the HIV-1-positive partner, multiplied by the number of months of follow-up for each couple, and then summed over all couples. In the Poisson regression,19 adjusted rate ratios of transmission per act were estimated, incorporating covariates for sex of the HIV-1-positive partner, quartiles of age (15-24, 25-29, 30-34, and >35 years), quartiles of viral load (38 500 copies/mL), and STD symptoms and diagnoses in the HIV-1-positive partner.
The probability of HIV-1 transmission per sex act was estimated as follows: the probability of transmission in the "i"th couple (Pi), depends on the number of acts during the follow up period (ni), and is 1-(1-γ)ni, where the infectivity (γ), is the probability of transmission per act.1,20 Overall infectivity and 95% CI were estimated without adjustment for covariates. Allowing the infectivity to depend on covariates (eg, quartiles of age and viral load) through a complementary log-log link leads to the regression model [log-log (1-P)]=log ni + b0 + b1X1, where b1 and X1 are vectors of regression coefficients and covariates, respectively. This model was fitted by use of statistical methods for generalised linear models, specifically binomial regression with a complementary log-log link and offset term log ni (SAS Institute, Cary, NC, USA).20 Various regression models were fitted with several covariates, including quartiles of age and HIV-1 viral load, sex, STD symptoms (genital ulcer disease, or discharge or dysuria), and STD diagnoses of the HIV-1-infected partner. Sex-specific models were also fitted for HIV-1-positive male circumcision status, and for HIV-1-positive female diagnoses of bacterial vaginosis and trichomonas. Covariates significant at p<0·1 were included in final models. These include single covariate models (separately for quartiles of age or viral load), and combined covariate models with both age and HIV-1 viral load, as well as combined models for genital ulcer disease and viral load. Goodness of fit was assessed by χ2 test relative to a saturated model.
Among the 174 HIV-discordant monogamous couples, the HIV-1-positive partners had a median age of 29·0 years (mean 30·2), and a median viral load of 12 476 copies/mL. In 97 couples, the male partner was HIV-1-positive, 17 of whom transmitted the virus to their wives (17·5%). In 77 couples, the woman was the HIV-1-positive partner, 21 of whom transmitted HIV-1 to their husbands (27·3%). HIV-1-infected men were significantly older than infected women (mean ages 34·0 years and 27·1, respectively; p<0·0001).
The mean reported frequency of intercourse was 8·9 (median 8·0) acts per month in the whole population. Among the 97 couples in which the man tested HIV-1 positive first, the infected men reported a mean of 8·3 (SE 0·70) acts of intercourse per month, and their HIV-1-negative female partners reported 8·8 (0·62) acts per month (p=0·49). In the 77 couples in which the woman tested HIV-1 positive first, the infected women reported 9·7 (0·76) acts per month, and their HIV-1-negative male partners reported 9·8 (0·62) acts per month (p=0·67). Thus, there was relatively good agreement in the sexual frequency independently reported by both members of couples. There were no significant differences in the frequency of intercourse reported by infected men versus infected women (p>0·20). As shown in table 1, the frequency of intercourse declined with older age, although the overall trend was not significant (p=0·2). Coital frequency was 10·0 per month for ages 15-24, compared with 7·4 per month for individuals older than 35 years (p=0·06). Among HIV-1-infected individuals, coital frequencies declined with higher viral loads: the mean frequency of intercourse was 10·4 acts per month in individuals with viral loads of less than 1700 copies/mL, whereas the frequency was 7·9 among those with viral loads greater than 38 500 copies/mL (p=0·10).
Transmissions Average Mean Adjusted rate
per couple sex follow-up ratio (95% CI)*
per month (months)
Either 38/174 8·92 22·6
Woman HIV+ 21/77 9·74 22·1 1·00
Man HIV+ 17/97 8·27 23·1 0·78 (0·62-2·68)
15-24 12/45 10·02 22·5 2·15 (0·80-6·43)
25-29 15/46 8·98 22·4 2·06 (0·83-5·86)
30-34 5/43 9·11 21·7 0·62 (0·18-2·08)
35-59 6/40 7·44 24·4 1·00
HIV-1 viral load (copies/mL)
<1700 1/43 10·40 26·0 1·00
1700-12 499 11/45 9·38 22·0 16·1 (3·11-295·71)
12 500- 11/42 7·98 23·0 17·91 (3·44-328·65)
>38 500 15/44 7·91 18·8 27·7 (5·42-506·79)
Genital ulcer disease
Yes 4/19 7·16 19·0 2·58 (1·03-5·69)
No 34/155 9·14 155·0 1·00
*Adjusted rate ratio of transmission per coital act. Poisson regression with quartiles of viral load, age, sex, and genital ulcer disease of HIV-positive partner. Table 1: Frequency of intercourse and relative risk of HIV transmission
Table 1 shows the rate ratio of transmission per coital act estimated from Poisson regression. The rate ratio of transmission was lower for HIV-1-positive men than for HIV-1-positive women, although this difference was not significant. Compared with HIV-1-infected individuals aged 35-59, the risk of transmission risk per sex act was higher among younger people aged 15-24 and 25-29 years. Although these point estimates were not significant, a 2 test for trend was significant (p=0·04). Compared with individuals with HIV-1 viral loads of less than 1700 copies/mL, the adjusted rate ratios showed a dose response relation at higher viral loads (table 1). Genital ulcer disease in the HIV-1-positive partner was associated with an increased risk of transmission per act (table 1), but other STD symptoms or diagnoses in the HIV-1-infected partners were not associated with an increased risk of transmission (results not shown). The risk of transmission was not significantly affected by the circumcision status of HIV-1-positive male partners. All of these couples were married or in a stable consensual union; 161 (92·5%) had never used condoms, 11 (6·3%) reported occasional condom use, and only two (1·2%) reported consistent use. Thus, the effects of condom use on transmission risk could not be assessed in these monogamous couples.
The overall probability of transmission per coital act, unadjusted for covariates, was 0·0011 (95%CI 0·0008-0·0015). Table 2 shows the probabilities of HIV-1 transmission per coital act (γ), estimated from the complementary log-log binomial model for quartiles of age and HIV-1 viral load, and genital ulcer disease. The probability of transmission per act was highest for younger individuals aged 15-24 years and 25-29 years, and decreased at older ages. The transmission probability per act increased significantly with HIV viral load. At all viral loads, individuals aged 15-24 and 25-29 years had higher transmission probabilities per act than individuals older than 30 years, and in all age groups, the probability of transmission per act increased with viral load, but this association was most striking among the individuals younger than 30 years.
Viral load (copies/mL)
>1700 1700 12 500 >38 500
-12 499 -38 500
Age (years) Age† Age and viral load§
15-24 0·0013 0·0001 0·0020 0·0019 0·0032
25-29 0·0017 0·0001 0·0018 0·0026 0·0048
30-34 0·0006 0·00003 0·0005 0·0005 0·0014
35-59 0·0009 0·00004 0·0007 0·0008 0·0020
Viral load‡ 0·0001 0·0013 0·0014 0·0023
Genital ulcer disease¶
No 0·0041 0·0002 0·0033 0·0039 0·0049
Yes 0·0011 0·0001 0·0012 0·0014 0·0018
*Calculated from (1-exp [-exp (k)]), where k=ba+b1X and X is the vector of regression coefficients. +Model for age alone. ‡Model for viral load alone. §Model for age and viral load. ¶Model for genital ulcer disease and viral load.
Table 2: Probabilities of HIV-1 transmission per coital act*
HIV-1 subtyping was available for 155 infected individuals. 31 were infected with subtype A (20·0%), 103 subtype D (66·4%), and the remaining 21 (13·5%) had an atypical V3 subtype, which showed complex binding patterns. The transmission probabilities per coital act were 0·0022 with subtype A, 0·0019 with subtype D, and were lower with the atypical viruses (γ=0·0012). These differences were not significant (p=0·26).
The probability of transmission per act from HIV-1-positive women to their HIV-1-negative male partners was 0·0013, compared with a transmission probability of 0·0009 per act from HIV-1-positive men to HIV-1-negative women (p=0·34). The probability of transmission per act was higher if genital ulcer disease was reported by the HIV-1-positive partner than if it was not (=0·0041 vs =0·0011; p=0·02), and this higher transmission probability among individuals with ulceration was seen at all viral loads. The presence of genital discharge, dysuria, or laboratory STD diagnoses did not significantly affect the probability of transmission per act (results not shown).
La probabilidad en general de transmisión por acto coital de 0·0011 en la población Rakai está dentro del rango de probabilidades de transmisión por acto (0·0001-0·0020), informadas por lose studios prospectivos de parejas heterosexuales europeas, norteamericanas y tailandesas.2-7 El uso de condón era bajo en las parejas monógamas ugandesas; a pesar del hecho de que los condones y el aconsejamiento se ofrecían gratis y eran promovidos por el proyecto, 56% de los miembros de parejas HIV-1-positivos de estas relaciones discordantes habían rerquerido y recibido aconsejamiento VIH, y el 25% afirmaba que habían informado a sus parejas. Este resultado es consistente con estudios previos en Rakai que mostraban bajo uso del condón dentro del matrimonio21 En contraste, las investigaciones europeas, norteamericanas y tailandesas encontraron uso frecuente de condón entre parejas HIV-1 discordantes.3-7 Las epidemias europea y norteamericana son predominantemente causadas por el HIV-1 subtipo B, la epidemia tailandesa por los subtipos E y B, y la epidemia ugandesa por los subtipos A y D. Por lo tanto, como las probabilidades de transmisión por acto en la relación sexual penetrativa en estas poblaciones son similares, es improbable que la epidemia generalizada de HIV-1 en Uganda haya sido causada por la infecciosidad mayor de los subtipos A y D.
No vimos una diferencia en la probabilidad de transmisión por acto entre los subtipos HIV-1 A y D. Aunque la transmisión por acto parecía ser más baja con virus atípicos de loop V3, esta asociación no fue significativa. We do not yet have genomic sequence data on these atypical viruses, so we cannot determine whether the atypical V3 loop represents A or D, non-A/D, or possibly recombinant viruses. Nevertheless, the finding of a possibly lower transmission probability per act in individuals with atypical viruses is compatible with the hypothesis that atypical and possibly recombinant HIV-1 viruses might be less infectious than viruses with typical V3 loop sequences.13
Ours and other estimates of transmission probabilities per coital act among heterosexual couples are much lower than those reported for contacts with prostitutes in Thailand and Kenya.8,9 However, the Thai estimates were based on a cross-sectional study of prevalent HIV-1 among young military conscripts, and ascertained the life-time frequency of sexual contacts with prostitutes retrospectively.8 Recall of the frequency of commercial sexual contacts was likely to be subject to error, and under-reporting of the number of contacts could lead to overestimation of the per-contact risk. The Kenyan estimate was derived from a subgroup of men attending a STD clinic who reported a single contact with a sex worker.9 These estimates could also be biased by under-reporting of contact frequency. Alternatively, estimates from stable heterosexual couples might not reflect the probability of infection from a single unprotected act of intercourse with a randomly selected, high-risk partner, such as a prostitute.6 Some have suggested that coitus with prostitutes could be particularly hazardous owing to concurrent STDs or STD symptoms in the woman or her client.
We found a higher transmission probability per act among individuals who reported genital ulceration, but we did not see an increased probability of transmission per coital act among those with serological evidence of syphilis or HSV-2, and laboratory diagnoses of current gonorrhoea, chlamydia, bacterial vaginosis, or trichomonas infections, or among those reporting discharge or dysuria. With the exception of genital ulceration, the absence of an STD cofactor effect has been seen in previous analyses of HIV-1-discordant couples,15 and the frequent HIV-1 exposure risk in such couples could possibly obscure an association between STDs and the per-contact probability of transmission. Additionally, our study had limited power to detect STD cofactor associations. Because STD diagnoses were based on samples obtained at the visit preceding the period of seroconversion risk, some infections such as gonorrhoea and chlamydia were too infrequent to assess, and symptom reporting embraced the whole period of risk. Therefore, STDs or symptoms at the exact time of seroconversion cannot be accurately determined. Also, serological tests for syphilis and HSV-2 reflect cumulative infections, so initial seroconversion (or HSV-2 recurrence) might not coincide with the timing of HIV-1 transmission.
There was substantial heterogeneity in transmission probabilities in the Ugandan population: transmission probabilities per coital act were highest in younger individuals, and increased strikingly with HIV-1 viral load. Frequency of intercourse cannot explain the change in infectivity with age because this factor was controlled for in the models. Higher infectivity could possibly be due to biological factors such as cervical ectopy in younger women which might facilitate HIV-1 transmission. Partial immunity in older HIV-1-positive individuals or selective resistance to infection associated with repeated prior HIV-1 exposure in older HIV-1-negative partners might also be factors. Intercourse among younger people might be associated with more genital trauma, but we have no direct data on this issue. Anal intercourse is associated with a higher probability of transmission per sexual act,2 but anal intercourse is not practised in this population (fewer than 1% of individuals reported anal sex, and anorectal STDs are not seen). Other investigators have reported that the probability of HIV-1 transmission per sexual contact is higher among people who are immunocompromised or who have lower CD4 counts,2,5,9-11and this possibility is consistent with our finding of higher transmission probabilities per coital act associated with increased HIV-1 viral loads.
Los estudios de parejas serodiscordantes en Europa y los EEUU generalmente informan eficiencia de transmisión superior de varón a mujer que de mujer a varón, aunque estas investigaciones tuvieron pocos miembros de parejas índices positivos al HIV-1.2-5 por contraste, nosotros encontramos una probabilidad superior de transmisión por acto de mujeres a hombres que de hombres a mujeres, que, aunque no fue significativa, era consistente con los datos de incidencia previa de los Rakai entre parejas discordantes al 15,22 y en la población general.14 De modo similar, una transmisión superior de mujer a varón ha sido informada en otros países menos desarrollados23 Varios estudios africanos muestran que la prevalencia e incidencia de VIH-1 son superiors en mujeres jóvenes que en hombres jóvenes,12 pero estos datos sugieren que es improbable que los diferenciales sexoespecíficos de prevalencia de HIV-1 sean causados por diferencias de sexo en la eficiencia de la transmisión de HIV-1.
Las estimaciones de probabilidades de transmisión por acto coital se apoyan en la precision de la información sobre frecuencia sexual (sobrenotificación de frecuencia coital conduce a subestimación del riesgo por cada acto coital, y la subnotificación del de la frecuencia sexual conduce a una sobreestimación del riesgo por acto sexual). Otros estudios de probabilidades de transmisión por acto no han determinado la confiabilidad de la cantidad de actos sexuales notificados, y conmúnmente usan datos agrupados de frecuencia sexual para el análisis. Creemos que las frecuencias informadas de relaciones sexuales penetrativas en nuestro estudio son confiables porque hubo acuerdo en la cantidad de actos sexuales informados independientemente por los miembros de la pareja en estas relaciones monógamas, lo que sugiere consistencia de notificación dentro de las parejas, como se ha visto en otros estudies.24,25 También la frecuencia sexual notificada declinaba con la edad, como ocurre en la mayoría de las poblaciones,26 y la frecuencia de relación sexual penetrativa es compatible con la notificada en otras sociedades rurales africanas orientales.26,27 De este modo, no tenemos prueba que sugiera que los datos de frecuencia sexual introdujeron un sesgo en las estimaciones de probabilidades de transmisión por acto sexual.
La probabilidad en general, no ajustada, de transmisión por acto coital as de 0·0011 en esta población ugandesa population, y es improbable que la mayor infectividad de los subtipos virales de HIV-1 explique la explosiva epidemia de HIV-1 en el África subsahariana. La probabilidad de transmisión por acto varía grandemente con la carga viral de HIV-1 del miembro de la parejas infectado con HIV-1, lo que sugiere que las intervenciones que reduzcan la carga viral podrían reducir la transmisión.15,28 La edad más joven y la ulceración genital también aumentaron las probabilidades de transmisión por acto sexual.
R H Gray, M J Wawer, N K Sewankambo, D Serwadda, and F Wabwire-Mangen were responsible for the design and implementation of the original trial, and contributed to the analyses of this subsample of HIV-1-discordant couples. T Lutalo was the data manager overseeing the trial and contributed to these analyses. R Brookmeyer and X Li were responsible for the statistical analysis of transmission probabilities per coital act. T vanCott provided the HIV-1 subtyping assays and T Quinn did the HIV-1 viral load assays. All investigators contributed to the preparation of the paper.
Rakai Project Team
Noah Kiwanuka, Godfrey Kigozi, Fred Nalugoda, Mohamed Kiddagavu, and Fred Makumbi (Uganda Virus Research Institute, Entebbe, Uganda).
We thank Andre Nahmias (Emory University, Atlanta, GA, USA) for the HSV-2 assays, and S K Sempalla (Director, Uganda Virus Research Institute) for his support. The study was supported by grants RO1 AI34826 and RO1 AI3426S from the National Institute of Allergy and Infectious Diseases; grant 5P30HD06826 from the National Institute of Child Health and Development; grant 5D43TW00010 from the Fogarty Foundation; the US National Institutes of Health; the World Bank STI Project, Uganda; and the GlaxoWellcome Foundation.
Brookmeyer R, Gail MH. AIDS epidemiology: a quantitative approach. New York: Oxford University Press, 1994: 36-50.
Royce RA, Sena A, Cates W, Cohen MS. Sexual transmission of HIV. N Engl J Med 1997; 336: 1072-78.
Mastro TD, Kitayaporn D. HIV type 1 transmission probabilities: estimates from epidemiologic studies. AIDS Res Hum Retrovirol 1998; 14 (Suppl 3): S223-27.
Padian N, Shiboski SC, Jewell NP. Female-to-male transmission of human immunodeficiency virus. JAMA 1991; 266: 1664-67.
Nicolosi A, Leite MLC, Musicco M, Arici C, Gavazzeni G, Lazzarin A, for the Italian Study Group on HIV Heterosexual Transmission. The efficiency of male-to-female and female-to-male sexual transmission of the human immunodeficiency virus: a study of 730 stable couples. Epidemiology 1994; 5: 570-75.
De Vincenzi I, for the European Study Group in Heterosexual Transmission of HIV. A longitudinal study of human immunodeficiency virus transmission by heterosexual couples. N Engl J Med 1994; 331: 341-46.
Duerr A, Xia Z, Nagachinta T, Tovanbutra S, Tansuhaj A, Nelson K. Probability of male-to-female HIV transmission among married couples in Chiang Mai, Thailand. 10th International Conference on AIDS, Yokahama, Japan, August 1994 (abstr).
Mastro TD, Satten GA, Nopkesorn T, Sangkharomya S, Longini IM. Probability of female-to-male transmission of HIV-1 in Thailand. Lancet 1994; 434: 204-07.
Cameron DW, Simonsen JN, D'Costa LJ, et al. Female to male transmission of human immunodeficiency virus type 1: risk factors for seroconversion in men. Lancet 1989; 2: 403-07.
Mayer KH, Anderson, DJ. Heterosexual HIV transmission. Infect Agents Dis 1995; 4: 273-84.
O'Brien TR, Busch MP, Donegan E, et al. Heterosexual transmission of human immunodeficiency virus type 1 from transfusion recipients to their sex partners. J Acquir Immune Defic Syndr Hum Retrovirol 1994; 7: 705-10. [PubMed]
Schwartlander B, Garnett G, Walker N, Anderson R. AIDS in the new millennium. Science 2000; 289: 64-66.
McCutchan F, Carr JK, Robb M, et al. Full genome sequencing of HIV-1 reveals new complexity in the pandemic. 13th International AIDS Conference, Durban, South Africa, July, 2000 (abstr).
Wawer MJ, Sewankambo NK, Serwadda D, et al. Control of sexually transmitted diseases for AIDS prevention in Uganda: a randomised community trial. Lancet 1999; 353: 525-35.
Quinn TC, Wawer MJ, Sewankambo N, et al, for the Rakai Project Study Group. Viral load and heterosexual transmission of human immunodefficiency virus type 1. N Engl J Med 2000; 342: 921-29.
AIDS Control Programme. HIV testing policy. Entebbe, Uganda: Ministry of Health, 1992: 1-8.
Sanchez-Martinez D, Schmid DS, Whittington W, et al. Evaluation of a test based on Baculovirus-expressed glycoprotein G for detection of herpes simplex virus type-specific antibodies. J Infect Dis 1991; 164: 1196-99.
Renzullo P, Sateran W, McCutchan F, et al. HIV-1 V3 serotypes among civilian applications for US military service, 1989-1998. 13th International AIDS Conference, Durban, South Africa, July, 2000 (abstr).
Breslow NE, Day NE. Statistical methods in cancer research, vol. 2: the design and analysis of cohort studies. Lyon: International Agency for Research on Cancer, 1987.
Jewell NP, Shiboski S. Statistical analysis of HIV infectivity based on partner studies. Biometrica 1990; 46: 1133-50.
Lutalo T, Kidugavu M, Wawer MJ, Serwadda D, Zabin LS, Gray RH. Trends and determinants of contraceptive use in Rakai District, Uganda, 1995-98. Stud Fam Plan 2000; 31: 217-27.
Serwadda D, Gray RH, Wawer MJ, et al. The social dynamics of HIV transmission as reflected through discordant couples in rural Uganda. AIDS 1995; 9: 745-50.
O'Farrell N. Enhanced efficiency of female-to-male HIV transmission in core groups in developing countries. STDs 2001; 28: 84-91.
Lagarde E, Enel C, Pison G. Reliability of reports of sexual behavior: a study of married couples in rural West Africa. Am J Epidemiol 1995; 141: 1194-200.
Upchurch DM, Weisman CS, Shepard M, et al. Interpartner reliability of reporting of recent sexual behaviors. Am J Epidemiol 1991; 134: 1159-66.
Blanc AK, Rutenberg N. Coitus and contraception: the utility of data on sexual intercourse for family planning programs. Stud Fam Plan 1991; 22: 162-76.
Schopper D, Doussantousse S, Orav J. Sexual behaviors relevant to HIV transmission in a rural African population. Soc Sci Med 1993; 37: 401-12.
Cohen MS. Preventing sexual transmission of HIV: new ideas from sub-Saharan Africa. N Engl J Med 2000; 342: 970.
Departments of Population and Family Health Sciences (R H Gray MD, X-B Li PhD), Biostatistics (R Brookmeyer PhD), and Medicine (T C Quinn MD), School of Hygiene and Public Health, Johns Hopkins University, Baltimore, MD, USA; Heilbrun Center for Population and Family Health, Columbia University, Joseph L Mailman School of Public Health, New York, NY, USA (M J Wawer MD); Department of Medicine and Clinical Epidemiology Unit (N K Sewankambo MB) and Institute of Public Health (D Serwadda MB, F Wabwire-Mangen PhD), Makerere University, Kampala, Uganda; Rakai Project, Uganda Virus Research Institute, Entebbe, Uganda (T Lutalo MSc); Walter Reed Army Institute of Research, Rockville, MD (T vanCott PhD); and National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD (T C Quinn)
Correspondence to: Dr Ronald H Gray, Suite 4030, Johns Hopkins University, School of Hygiene and Public Health, 615 N Wolfe Street, Baltimore, MD 21205, USA